REG - Induction Healthcare - Distribution agreement for Zesty with System C

Induction HealthcareAnnouncement

11/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220711:nRSK9173Ra&default-theme=true

RNS Number : 9173R  Induction Healthcare Group PLC   11 July 2022

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Distribution agreement for Induction Zesty with System C

 

Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that it has signed a
non-exclusive Software Reseller Agreement ('the Agreement') with System C
Healthcare Limited ('System C'), a supplier of health and social care
information technology systems and services, for the Induction Zesty product
in the UK.

 

Induction Zesty is a digital patient engagement portal that enables end-to-end
healthcare management. The portal's interface provides a fully automated
process for patients to manage their hospital appointments, view their letters
and clinical records, as well as provide data remotely via digital
questionnaires from a smartphone.

 

System C specialises in providing health and social care solutions across
whole care communities. Their product portfolio includes the CareFlow EPR, an
electronic patient record system ('EPR'), which is currently used in 30 NHS
Trusts across the UK. As part of the agreement, System C will now actively
sell Induction Zesty into its new and existing customers using CareFlow EPR.
The non-exclusive agreement covers an initial three-year term with automatic
12 month renewals thereafter.

 

NHS Trusts are looking for solutions which require minimum procurement but
provide maximum impact. System C is able to link information from multiple
systems to integrate workflows between care settings and support
multi-provider reporting and analysis. As a result of this agreement, the
procurement of Induction Zesty will be easy and more accessible for NHS Trusts
already using CareFlow EPR and a proven, effective solution for new customers.

 

This comes at a time of significant national focus and spending on digital
transformation for NHS secondary care providers in England, which is outlined
in the NHS Long Term Plan(1). Digitisation, especially through EPRs, is even
more important to help tackle the backlog of elective care appointments
following COVID-19 and support NHS Trusts to meet the new Minimum Digital
Foundations requirements. System C has committed to providing solutions to
address all aspects of NHS Long Term Plan and with 500K unique users already,
Induction Zesty is a secure solution to support the government-led drive for
patient portals in all UK hospitals.

 

(1) https://www.longtermplan.nhs.uk/ (https://www.longtermplan.nhs.uk/)

 

Induction CEO, James Balmain, said: "We have a long-standing relationship
with System C, one of the largest domestic suppliers of EPR software to the
NHS, and it is a great step forward to be formally partnered with them under a
value-added reseller agreement. Given System C's market share and their
ability to reach customers efficiently via their direct sales force, we expect
to see significant revenue generated via this partnership over the coming
years.

 

"Together with our value-added reseller agreement with Cerner Corporation, we
now have access to over 40% of Acute hospitals through reseller agreements.
This agreement with System C acts as further material reinforcement of our
strategy to partner with, and build on top of, the key underlying systems used
by hospitals."

 

Guy Lucchi, Managing Director of Healthcare at System C, said: "We are very
pleased to be partnering with Induction. The Zesty patient portal is a
welcome addition to our integrated EPR offering which will empower patients to
receive and view their clinical appointment bookings and letters as well as
reschedule and cancel appointments within the portal, via a direct link to
CareFlow EPR."

 

 

-ENDS-

 

ENQUIRIES

 

 Induction                                                 Via Walbrook PR Ltd: induction@walbrookpr.com

                                                         (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer
 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)     +44 (0)20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd              +44 (0)20 7933 8780 or induction@walbrookpr.com
                              (mailto:induction@walbrookpr.com)
 Alice Woodings / Paul McManus                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

About System C Healthcare Limited - www.systemc.com (https://www.systemc.com/)

 

System C is a British technology company that has been supporting the NHS and
social care for almost forty years. The organisation is a leading supplier in
acute EPRs with 30 NHS Trusts. We are also the number one supplier in child
health, a pioneer in electronic observations with over 38 Trusts using our
systems, the fastest growing supplier in social care with 60% of councils and
the market leader in hospital pharmacy and medicines management where we
support £5bn+ medications per year across 350+ hospitals. Plus, we are the
national provider of the COVID and flu vaccination system, NIMS.

 

Our Care Alliance partner, Graphnet, is the number one supplier in shared care
records holding data on over 20m citizens, the number one supplier in
population health analytics with over 17.3m citizens covered and provides
remote monitoring to over 50,000 citizens.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRFZGGNVRLGZZM